Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2018 Aug 12;2018(3):32.
doi: 10.21542/gcsp.2018.32.

Heart transplantation in patients with hypertrophic cardiomyopathy

Affiliations
Review

Heart transplantation in patients with hypertrophic cardiomyopathy

Marta Farrero Torres et al. Glob Cardiol Sci Pract. .
No abstract available

PubMed Disclaimer

References

    1. Harris KM, Spirito P, Maron MS, Zenovich AG, Formisano F, Lesser JR, Mackey-Bojack S, Manning WJ, Udelson JE, Maron BJ. Prevalence, clinical profile, and significance of left ventricular remodeling in the end-stage phase of hypertrophic cardiomyopathy. Circulation. 2006;114(3):216–225. doi: 10.1161/CIRCULATIONAHA.105.583500. - DOI - PubMed
    1. Melacini P, Basso C, Angelini A, Calore C, Bobbo F, Tokajuk B, Bellini N, Smaniotto G, Zucchetto M, Iliceto S, Thiene G, Maron BJ. Clinicopathological profiles of progressive heart failure in hypertrophic cardiomyopathy. Eur Heart J. 2010;31(17):2111–2123. doi: 10.1093/eurheartj/ehq136. - DOI - PMC - PubMed
    1. Fernández A, Vigliano CA, Casabé JH, Diez M, Favaloro LE, Guevara E, Favaloro RR, Laguens RP. Comparison of prevalence, clinical course, and pathological findings of left ventricular systolic impairment versus normal systolic function in patients with hypertrophic cardiomyopathy. Am J Cardiol. 2011;108(4):548–555. doi: 10.1016/j.amjcard.2011.03.083. - DOI - PubMed
    1. D’Amato R, Tomberli B, Castelli G, Spoladore R, Girolami F, Fornaro A, Caldini A, Torricelli F, Camici P, Gensini GF, Cecchi F, Olivotto I. Prognostic value of N-terminal pro-brain natriuretic Peptide in outpatients with hypertrophic cardiomyopathy. Am J Cardiol. 2013;112(8):1190–1196. doi: 10.1016/j.amjcard.2013.06.018. - DOI - PubMed
    1. Masri A, Pierson LM, Smedira NG, Agarwal S, Lytle BW, Naji P, Thamilarasan M, Lever HM, Cho LS, Desai MY. Predictors of long-term outcomes in patients with hypertrophic cardiomyopathy undergoing cardiopulmonary stress testing and echocardiography. Am Heart J. 2015;169(5):684–692.e1. doi: 10.1016/j.ahj.2015.02.006. - DOI - PubMed

LinkOut - more resources